Skip to content
10-K

Annual Report

Aura Biosciences, Inc. AURA

0001193125-26-130401

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 24, 2026 64.15M sh
Shares Diluted FY 2025 · Dec 31, 2025 60.34M sh
Shares Diluted FY 2025 · Dec 31, 2024 49.65M sh
Capex FY 2025 · Dec 31, 2025 $447K
Capex FY 2025 · Dec 31, 2024 $1.25M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$84.74M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$79.81M
Cash And Equivalents FY 2025 · Dec 31, 2025 $59.52M
Cash And Equivalents FY 2025 · Dec 31, 2024 $31.69M
Stockholders Equity FY 2025 · Dec 31, 2025 $136.91M
Stockholders Equity FY 2025 · Dec 31, 2024 $151.97M
Stockholders Equity FY 2025 · Dec 31, 2023 $225.85M
Current Liabilities FY 2025 · Dec 31, 2025 $18.38M
Current Liabilities FY 2025 · Dec 31, 2024 $14.91M
Total Liabilities FY 2025 · Dec 31, 2025 $32.52M
Total Liabilities FY 2025 · Dec 31, 2024 $30.53M
Current Assets FY 2025 · Dec 31, 2025 $149.74M
Current Assets FY 2025 · Dec 31, 2024 $160.62M
Total Assets FY 2025 · Dec 31, 2025 $169.43M
Total Assets FY 2025 · Dec 31, 2024 $182.5M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.76
Eps Diluted FY 2025 · Dec 31, 2024 −$1.75
Eps Basic FY 2025 · Dec 31, 2025 −$1.76
Eps Basic FY 2025 · Dec 31, 2024 −$1.75
Sga Expense FY 2025 · Dec 31, 2025 $22.49M
Sga Expense FY 2025 · Dec 31, 2024 $22.81M
Rd Expense FY 2025 · Dec 31, 2025 $90.3M
Rd Expense FY 2025 · Dec 31, 2024 $73.3M
Net Income FY 2025 · Dec 31, 2025 −$106.19M
Net Income FY 2025 · Dec 31, 2024 −$86.92M
Operating Income FY 2025 · Dec 31, 2025 −$112.79M
Operating Income FY 2025 · Dec 31, 2024 −$96.12M